Positive effect of erythromycin on ineffective oesophageal motility in laryngopharyngeal reflux patients: Room for a novel treatment?
- 29 December 2024
- journal article
- research article
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 45 (1)
Abstract
Introduction: Laryngopharyngeal reflux (LPR) management guidelines are currently derived from the management of gastroesophageal reflux disease (GORD) which has been shown to be poorly effective in controlling symptoms for these patients. Erythromycin is a macrolide antibiotic that has been used extensively as a prokinetic agent for the gastrointestinal tract. The management of LPR with prokinetics is a novel therapy being investigated with regard to its effectiveness. The purpose of this pilot study was to observe the effect of erythromycin on oesophageal motility with high resolution manometry (HRM) to establish if further study is warranted regarding its utility in management.Methods: Consecutive patients were retrospectively identified from a prospectively maintained database at a single centre of patients with findings suggestive of LPR who had also undergone HRM. These patients all received lifestyle modification and erythromycin 250 mg BD with repeat HRM after 6 weeks of therapy.Results: 16 patients met inclusion criteria. Mean age was 56.2 ± 14.9. Mean ineffective swallows were 54.38% ± 41.3% compared with 34.4% ± 35.2% pre and post‐erythromycin therapy (p = 0.018). Mean distal contractile integral at baseline was 793.61 ± 854.96 mmHg at baseline increasing to 1347 ± 1094.73 mmHg after erythromycin therapy (p = 0.013). IRP also showed improvement from 8.99 ± 7.58 increasing to 10.93 ± 7.9 mmHg (p = 0.045). Subgroup analysis of patients with ineffective oesophageal motility reinforced above findings as well as increase in the amount of ‘normal’ peristalsis.Conclusion: This pilot study shows early evidence that erythromycin improves oesophageal motility. Further study is warranted to explore these findings in more detail.Keywords
This publication has 14 references indexed in Scilit:
- Post‐reflux swallow‐induced peristaltic wave is impaired in laryngopharyngeal and gastro‐oesophageal reflux diseaseClinical Physiology and Functional Imaging, 2021
- Esophageal motility disorders on high‐resolution manometry: Chicago classification version 4.0©Neurogastroenterology & Motility, 2021
- Predictors of reflux aspiration and laryngo-pharyngeal refluxEsophagus, 2020
- Facts and fantasies in extra-oesophageal symptoms in GORDBest Practice & Research Clinical Gastroenterology, 2010
- Extraesophageal GERDGastroenterology Clinics of North America, 2008
- Non-achalasic motor disorders of the oesophagusBest Practice & Research Clinical Gastroenterology, 2007
- The Pathophysiology of GERD2006
- Oral erythromycin and symptomatic relief of gastroparesis: a systematic reviewAmerican Journal of Gastroenterology, 2003
- Erythromycin enhances oesophageal motility in patients with gastro‐oesophageal refluxAnz Journal of Surgery, 2001
- The Effect of Erythromycin on Human Esophageal Motility Is Mediated by Serotonin ReceptorsAmerican Journal of Gastroenterology, 2000